SC issues notice to Centre over use of Remdesivir and Favipiravir for Covid-19
The petitioner referred to the bench a recent report of the World Health Organization (WHO) and said nowhere had the two medicines been mentioned officially as a cure for the novel coronavirus.
2 min read
The Supreme Court of India. (Express Photo/File)The Supreme Court Thursday issued notice to the Centre on a plea which alleged two drugs — Remdesivir and Favipiravir — were being promoted for treatment of Covid-19 patients without clearance from regulatory authorities.
A bench headed by Chief Justice of India S A Bobde and comprising Justices A S Bopanna and V Ramasubramaian issued notice with the rider that it was doing so only to make the government aware of the matter.
Petitioner Advocate M L Sharma referred to the bench a recent report of the World Health Organization (WHO) and said nowhere had the two medicines been mentioned officially as a cure for the novel coronavirus.
He contended the drugs were neither a vaccine nor a medicine for Covid-19 treatment, and could not be allowed to be supplied till it was declared so by regulatory authorities.
The petitioner added the drugs were only allowed to be tested during emergencies.
You May Like
Photos
